COYA CIK: 1835022

Coya Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−3.90
FY22:
−7.24
FY23:
−11.2
FY24:
−10.3
FY25:
−10.7
Change from FY21 to FY25
millions USD
FY21:
−0.14
FY22:
−0.53
FY23:
−0.54
FY24:
−0.03
FY25:
−1.16
Change from FY21 to FY25
millions USD
FY21:
−0.34
FY22:
9.36
FY23:
38.4
FY24:
16.0
FY25:
20.4

All amounts in millions USD Data source:SEC EDGAR